AptarGroup (NYSE:ATR) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

AptarGroup (NYSE:ATR – Get Free Report) announced its quarterly earnings results on Thursday. The industrial products company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.47 by $0.05, Zacks reports. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $980.76 million. AptarGroup had a return on equity of 13.31% and a net margin of 9.22%. The company’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.62 EPS.

AptarGroup Price Performance

NYSE ATR traded up $6.95 on Friday, reaching $137.59. The company’s stock had a trading volume of 349,371 shares, compared to its average volume of 490,680. AptarGroup has a 52 week low of $103.23 and a 52 week high of $146.91. The firm has a market cap of $8.75 billion, a PE ratio of 24.92, a price-to-earnings-growth ratio of 3.94 and a beta of 0.34. The business has a 50-day moving average price of $125.79 and a 200 day moving average price of $126.95. The company has a current ratio of 1.61, a quick ratio of 1.10 and a debt-to-equity ratio of 0.42.

AptarGroup Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 12th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, November 12th. This is a boost from AptarGroup’s previous quarterly dividend of $0.48. AptarGroup’s payout ratio is 34.72%.

Analyst Ratings Changes

ATR has been the topic of a number of recent analyst reports. Bank of America raised shares of AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 price target on the stock in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of AptarGroup in a research note on Wednesday, October 7th. They issued a “buy” rating and a $150.00 price target for the company. Raymond James Financial reaffirmed an “outperform” rating and issued a $160.00 price objective on shares of AptarGroup in a report on Wednesday, July 15th. Weiss Ratings reissued a “hold (c)” rating on shares of AptarGroup in a report on Monday, September 21st. Finally, UBS Group started coverage on shares of AptarGroup in a report on Friday, October 9th. They issued a “neutral” rating and a $135.00 price objective for the company. Six research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $164.14.

Get Our Latest Stock Report on AptarGroup

Insider Activity at AptarGroup

In other news, insider Shiela Vinczeller sold 765 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total value of $99,733.05. Following the transaction, the insider owned 26,313 shares of the company’s stock, valued at $3,430,425.81. This represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gael Touya sold 3,740 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $133.76, for a total transaction of $500,262.40. Following the completion of the sale, the chief executive officer owned 29,102 shares in the company, valued at approximately $3,892,683.52. This trade represents a 11.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 23,197 shares of company stock worth $3,134,828 in the last 90 days. Corporate insiders own 0.73% of the company’s stock.

AptarGroup News Roundup

Here are the key news stories impacting AptarGroup this week:

  • Positive Sentiment: Third-quarter results exceeded expectations. AptarGroup reported revenue of approximately $1.02 billion, up 6.0% year over year and above the roughly $981 million consensus estimate. Adjusted EPS of $1.52 also topped analyst expectations of approximately $1.46-$1.47. AptarGroup third-quarter earnings report
  • Positive Sentiment: Dividend increased. The board raised the quarterly payout 4.2%, from $0.48 to $0.50 per share, equivalent to $2.00 annually and a yield of about 1.4%. The dividend is payable December 3 to shareholders of record on November 12. Aptar increases quarterly dividend
  • Neutral Sentiment: Revenue growth was not matched by earnings growth. Gross profit rose 2.7% to $372.9 million, but operating profit fell 1.4%. One report cited adjusted EPS of $1.52, while third-party data showed GAAP diluted EPS of $0.51, down sharply year over year, highlighting the impact of adjustments and weaker underlying profitability. AptarGroup third-quarter financial results
  • Negative Sentiment: Reported cash generation and net income weakened. Third-party figures showed net income attributable to common shareholders of $32.6 million and operating cash flow of $167.6 million, while capital spending reached $69.0 million. In addition, reported insider activity over the past six months consisted of sales and no purchases, a potential confidence signal investors may monitor. AptarGroup Q3 revenue growth and EPS report

AptarGroup Company Profile

(Get Free Report)

AptarGroup, Inc (NYSE: ATR) develops and manufactures dispensing, sealing and delivery systems for the pharmaceutical, beauty, personal care, food and beverage markets. Its products are designed to control, protect and dispense a wide range of liquids, creams, lotions, fragrances and other formulations.

The company’s offerings include pumps, valves, closures, aerosol systems and other dispensing components, as well as drug-delivery technologies. Through its pharmaceutical business, Aptar supports nasal, pulmonary, ophthalmic, dermal and injectable applications, serving pharmaceutical and biotechnology companies with components and systems used in prescription, over-the-counter and consumer health products.

Aptar serves customers internationally through manufacturing, research and development and commercial operations across North America, Europe, Asia and other global markets.

Recommended Stories

Earnings History for AptarGroup (NYSE:ATR)

Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.